课题基金 / 基金详情

项目摘要

项目成果

CHERYL S WATSON的其他基金

相似基金

相关文献

中文摘要
翻译
转化成瘾科学中心的细胞生物学和药理学核心(核心B) (TASC)旨在通过减少跨科学项目的障碍, 从细胞到人类的界限。TASC的中心研究主题是冲动行为和线索 反应性与通过5-HT 2A破坏的5-HT神经传递机制有关 5-HT_2AR和5-HT_2cR定位于皮质纹状体回路。收购新的蜂窝和 5-HT 2AR:5-HT 2CR平衡的分子知识对于理解5-HT神经生物学如何 导致临床脆弱性和成瘾有证据表明,5-HT 2AR和5-HT 2cR发挥作用, 对冲动性和线索反应性的相反影响。然而,潜在的神经生物学基础 这种对立还没有被很好地理解,特别是因为这些高度同源的受体通过 类似的下行信令机制。为了解决这一根本性的差距, 这些受体的区域、细胞定位和神经元分布,以及对其他受体的评估。 影响受体功能状态的因素,如配体定向信号传导(项目3), 受体多态性(项目1)和受体寡聚化(项目2,项目3)。的 核心B的主要目标是作为细胞生物学的集中、综合来源, 药理学知识和技术专长,以最大限度地了解神经生物学和 5-HT 2AR的药理学特征:5-HT 2CR功能调节有助于破坏 总冲动性/线索反应性的稳态平衡。为此目的。核心B将:开发一个 稳定转染的5-HT 2 R细胞系用于筛选配体(项目3),使用生物反应测定法, 对表型和治疗反应的功能选择性(项目1和2);进行基因型 测定(项目1); 5-HT 2AR:5-HT 2CR在细胞和区域的图激活和共定位 冲动大鼠的前额叶-纹状体-丘脑回路内的水平;利用生物反应测定, 确定项目3中的哪些新配体将在动物行为模型(项目2)中进行测试, 塑造未来的人类实验(项目1);确定5-HT 2A +2CR二聚化在控制 受体功能以及新合成的二价5-HT 2 R配体的作用(项目3)。这个强大 将遗传学、化学和功能筛选与新药分析相结合的方法将所有 TASC项目,并将提供不可或缺的信息基础,以证明5 HT 2AR:5-HT 2CR稳态失衡是可卡因依赖行为表现的基础, 5-HT 2AR:5-HT 2CR平衡的恢复将修复皮质纹状体缺陷并改善复发。 相关性: 目前没有有效的、可获得的治疗兴奋剂成瘾的药物。使用 培养细胞,我们将筛选新创建的药物,以测试它们在啮齿动物试验中的潜力, 人类吸毒,并最终在临床试验中作为治疗兴奋剂成瘾的新药物。
英文摘要
The Cellular Biology and Pharmacology Core (Core B) of the Translational Addiction Sciences Center (TASC) is designed to bridge the scientific projects and engender synergy by mitigating barriers across the boundaries from cells to humans. The central research theme ot the TASC is that impulsive action and cue reactivity are mechanistically linked to disrupted serotonin (5-HT) neurotransmission through the 5-HT2A receptor (5-HT2AR) and 5-HT2cR localized to the corticostriatal circuitry. The acquisition of new cellular and molecular knowledge of the 5-HT2AR:5-HT2CR balance is necessary to understand how 5-HT neurobiology drives clinical vulnerability profiles and addiction. Evidence indicates that 5-HT2AR and 5-HT2cR exert opposing influence upon both impulsivity and cue reactivity. However, the neurobiological basis underlying this opposition is not well understood, particularly since these highly homologous receptors work through similar downstream signaling mechanisms. To address this fundamental gap, a greater understanding of the regional, cellular localization and neuronal distribution of these receptors, as well as an assessment of other factors that influence the functional status of the receptors, such as ligand directed signaling (Project 3), receptor polymorphisms (Project 1) and receptor oligomerization (Project 2, Project 3), is needed. The primary objective tor Core B is to serve as a centralized, integrative source of cellular biology and pharmacology knowledge and technical expertise, to maximize our understanding of the neurobiological and pharmacological features of 5-HT2AR:5-HT2CR functional regulation that contribute to the disruption of homeostatic balance in aggregate impulsivity/cue reactivity. To this end. Core B will: develop a library of stably-transfected 5-HT2R cell lines for screening ligands (Project 3) using bioresponsive assays to relate functional selectivity to phenotypes and treatment responses (Projects 1 and 2); conduct genotype determinations (Project 1); map activation and co-localization of 5-HT2AR:5-HT2CR at the cellular and regional levels within the prefrontal-striatal-thalamic circuits of impulsive rats; utilize bioresponsive assays to determine which new ligands from Project 3 will be tested in animal behavioral models (Project 2) as we shape future experiments in humans (Project 1); determine the role of 5-HT2A+2CR dimerization in control of receptor function as well as effects of newly synthesized bivalent 5-HT2R ligands (Project 3). This powerful approach combining genetics, chemical and functional screens with new drug analyses ties together all of the TASC Projects and will provide an indispensable foundation of information to allow demonstration that 5 HT2AR:5-HT2CR homeostatic imbalance underlies behavioral manifestations of cocaine dependence and that restoration of the 5-HT2AR:5-HT2CR balance will repair corticostriatal deficits and ameliorate relapse. RELEVANCE: No effective, accessible medication for the treatment of stimulant addiction is currently available. Using cultured cells, we will screen newly created drugs for their potential to be tested in rodent assays that model human drug-taking and ultimately in clinical trials as novel medications for treatment of stimulant addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CELLULAR AND MOLECULAR BIOLOGY CORE
CELLULAR AND MOLECULAR BIOLOGY CORE
Nongenomic Signaling Mechanisms of Environmental Estrogens
Nongenomic Signaling Mechanisms of Environmental Estrogens
海外基金